Threatening drug‐drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID‐19)-Reference-Cited by-同舟云学术

Threatening drug‐drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID‐19)

Published:2020-07-14 Issue:4 Volume:22 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Bartiromo Marilù¹,Borchi Beatrice²^ORCID,Botta Annarita³^ORCID,Bagalà Alfredo³,Lugli Gianmarco³^ORCID,Tilli Marta³,Cavallo Annalisa²,Xhaferi Brunilda⁴,Cutruzzulà Roberta¹,Vaglio Augusto⁵⁶,Bresci Silvia²,Larti Aida¹,Bartoloni Alessandro²³,Cirami Calogero¹

Affiliation:

1. Nephrology Unit Careggi University Hospital Florence Italy

2. Infectious and Tropical Diseases Unit Careggi University Hospital Florence Italy

3. Department of Experimental and Clinical Medicine University of Florence Florence Italy

4. Nephrology Unit University of Milan‐Bicocca Milan Italy

5. Department of Biomedical, Experimental and clinical Sciences “Mario Serio” University of Florence Florence Italy

6. Nephrology and Dialysis Unit Meyer Children’s Hospital Florence Italy

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13286

Reference10 articles.

1. The first two cases of 2019‐nCoV in Italy: Where they come from?

2. Coronavirus disease 2019: Implications of emerging infections for transplantation

3. Severe Acute Respiratory Syndrome (SARS) in a Liver Transplant Recipient and Guidelines for Donor SARS Screening

4. MERS CoV Infection in Two Renal Transplant Recipients: Case Report

5. Successful recovery of COVID‐19 pneumonia in a renal transplant recipient with long‐term immunosuppression

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir;Clinical Microbiology and Infection;2023-05

4. COVID-19 and corticosteroids: a narrative review;Inflammopharmacology;2022-05-13

5. Identification of Drug Interaction Adverse Events in Patients With COVID-19;JAMA Network Open;2022-04-19